Circulating tumor DNA (ctDNA) testing + Datopotamab Deruxtecan

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Circulating tumor DNA (ctDNA) testing + Datopotamab Deruxtecan
Treatment and conditionWhere it standsTrials
Circulating tumor DNA (ctDNA) testing + Datopotamab Deruxtecan for neoplasm, residualPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1